Related references
Note: Only part of the references are listed.Critical link between glycogen synthase kinase 3β and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps
Xingmei Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Post-translational modification networks regulating FOXP3 function
Jorg van Loosdregt et al.
TRENDS IN IMMUNOLOGY (2014)
Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
Raghvendra M. Srivastava et al.
CLINICAL CANCER RESEARCH (2013)
The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3
Zuojia Chen et al.
IMMUNITY (2013)
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
Dietmar M. W. Zaiss et al.
IMMUNITY (2013)
Foxp3 Protein Stability Is Regulated by Cyclin-dependent Kinase 2
Peter A. Morawski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis
Hong Nie et al.
NATURE MEDICINE (2013)
An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection
Fei Chen et al.
NATURE MEDICINE (2012)
T cell-mediated moculation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects
Yoseph A. Mekori et al.
FRONTIERS IN IMMUNOLOGY (2012)
Amphiregulin Exosomes Increase Cancer Cell Invasion
James N. Higginbotham et al.
CURRENT BIOLOGY (2011)
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis
Qingqing Ding et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression
Christopher H. Crane et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Role of Glycogen Synthase Kinase 3 in Regulating IFN-β-Mediated IL-10 Production
Huizhi Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
Glycogen Synthase Kinase-3 Is an Early Determinant in the Differentiation of Pathogenic Th17 Cells
Eleonore Beurel et al.
JOURNAL OF IMMUNOLOGY (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Treatment With Interleukin-12/23p40 Antibody Attenuates Acute Cardiac Allograft Rejection
Aini Xie et al.
TRANSPLANTATION (2011)
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization
Jorg van Loosdregt et al.
BLOOD (2010)
Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer
Fusanori Yotsumoto et al.
CANCER SCIENCE (2010)
Posttranslational modifications of NF-kappa B: Another layer of regulation for NF-kappa B signaling pathway
Bo Huang et al.
CELLULAR SIGNALLING (2010)
Human basophils express amphiregulin in response to T cell-derived IL-3
Yilin Qi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Suppressive Regulatory T Cell Activity Is Potentiated by Glycogen Synthase Kinase 3β Inhibition
Jay A. Graham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tumor Antigen-Targeted, Monoclonal Antibody-Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Massively regulated genes: the example of TP53
Monica Hollstein et al.
JOURNAL OF PATHOLOGY (2010)
Comparative methodologies of regulatory T cell depletion in a murine melanoma model
Norimasa Matsushita et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells
Yi Ding et al.
NATURE MEDICINE (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TGF-β and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3
Arabinda Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The age of crosstalk: Phosphorylation, ubiquitination, and beyond
Tony Hunter
MOLECULAR CELL (2007)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies
Greta Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Amphiregulin:: A new growth factor in hepatocarcinogenesis
C. Berasain et al.
CANCER LETTERS (2007)
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression:: a role for DNA methylation
Hyoung-Pyo Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
Qingqing Ding et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Amphiregulin, a TH2 cytokine enhancing resistance to nematodes
Dietmar M. Zaiss et al.
SCIENCE (2006)
Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma
Zhi-Zhang Yang et al.
CANCER RESEARCH (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer
CD Thienelt et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts
SW Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Share Paper
